- Home
- GAME vs AIFF Comparison
GAME vs AIFF Comparison
Compare GAME & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- AIFF
- Stock Information
- Founded
- GAME 2011
- AIFF 2006
- Country
- GAME United States
- AIFF Canada
- Employees
- GAME N/A
- AIFF N/A
- Industry
- GAME
- AIFF
- Sector
- GAME
- AIFF
- Exchange
- GAME Nasdaq
- AIFF NYSE
- Market Cap
- GAME 25.8M
- AIFF 26.6M
- IPO Year
- GAME 2009
- AIFF N/A
- Fundamental
- Price
- GAME $0.90
- AIFF $7.79
- Analyst Decision
- GAME Strong Buy
- AIFF
- Analyst Count
- GAME 3
- AIFF 0
- Target Price
- GAME $3.67
- AIFF N/A
- AVG Volume (30 Days)
- GAME 297.3K
- AIFF 18.1M
- Earning Date
- GAME 04-15-2025
- AIFF 03-04-2025
- Dividend Yield
- GAME N/A
- AIFF N/A
- EPS Growth
- GAME N/A
- AIFF N/A
- EPS
- GAME N/A
- AIFF N/A
- Revenue
- GAME $99,072,646.00
- AIFF $74,000.00
- Revenue This Year
- GAME $102.01
- AIFF N/A
- Revenue Next Year
- GAME $17.88
- AIFF N/A
- P/E Ratio
- GAME N/A
- AIFF N/A
- Revenue Growth
- GAME 210.51
- AIFF N/A
- 52 Week Low
- GAME $0.65
- AIFF $1.86
- 52 Week High
- GAME $2.25
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- GAME 54.66
- AIFF 55.76
- Support Level
- GAME $0.84
- AIFF $7.11
- Resistance Level
- GAME $0.95
- AIFF $17.20
- Average True Range (ATR)
- GAME 0.06
- AIFF 2.04
- MACD
- GAME 0.00
- AIFF 0.15
- Stochastic Oscillator
- GAME 62.69
- AIFF 33.45
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.